Literature DB >> 6277913

Preparation of a pure monoiodo derivative of the bee venom neurotoxin apamin and its binding properties to rat brain synaptosomes.

M Hugues, D Duval, P Kitabgi, M Lazdunski, J P Vincent.   

Abstract

The preparation and purification of an active monoiodo derivative of apamin is described. Radiolabeled monoiodoapamin (2000 Ci/mmol) binds specifically to rat brain synaptosomes at 0 degrees C and pH 7.5 with a second order rate constant of association (ka = 2.6 x 10(7) M-1 s-1) and a first order rate constant of dissociation (kd = 3.8 x 10(-4) s-1). The maximal binding capacity is 12.5 fmol/mg of protein and the dissociation constant is 15-25 pM for the monoiodo derivative and 10 pM for the native toxin. The apamin receptor is destroyed by proteases suggesting that it is of a proteic nature. Neurotensin and its COOH-terminal partial sequences are the only molecules unrelated to apamin that are able to displace monoiodoapamin from its receptor at low concentrations. Half-displacement occurs at 170 nM neurotensin. This property is due to the presence in the COOH-terminal sequence of neurotensin of two contiguous arginine residues, a structure analogous to that of the apamin active site. The binding of monoiodoapamin to its receptor is sensitive to cations. Increasing K+ or Rb+ concentrations from 10 microM to 5 mM selectively enhances the binding by a factor of 1.8. Increasing the concentration of any cation from 1 to 100 mM completely inhibits iodoapamin binding. Both effects are due to a cation-induced modulation of the affinity of monoidoapamin for its receptor without any change of the maximal toxin binding capacity of synaptosomes. Guanidinium and molecules containing a guanidinium group are better inhibitors of iodoapamin binding than other inorganic cations or positively charged organic molecules.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277913

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Activation of small conductance Ca(2+)-dependent K+ channels by purinergic agonists in smooth muscle cells of the mouse ileum.

Authors:  F Vogalis; R K Goyal
Journal:  J Physiol       Date:  1997-08-01       Impact factor: 5.182

Review 2.  Use of toxins to study potassium channels.

Authors:  M L Garcia; A Galvez; M Garcia-Calvo; V F King; J Vazquez; G J Kaczorowski
Journal:  J Bioenerg Biomembr       Date:  1991-08       Impact factor: 2.945

3.  125I-Labelled mapacalcine: a specific tool for a pharmacological approach to a receptor associated with a new calcium channel on mouse intestinal membranes.

Authors:  P Vidalenc; J L Morel; J Mironneau; M Hugues
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

4.  Effects of apamin, quinine and neuromuscular blockers on calcium-activated potassium channels in guinea-pig hepatocytes.

Authors:  N S Cook; D G Haylett
Journal:  J Physiol       Date:  1985-01       Impact factor: 5.182

5.  Blockade of Ca-activated K conductance by apamin in rat sympathetic neurones.

Authors:  T Kawai; M Watanabe
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

Review 6.  An emerging pharmacology of peptide toxins targeted against potassium channels.

Authors:  E Moczydlowski; K Lucchesi; A Ravindran
Journal:  J Membr Biol       Date:  1988-10       Impact factor: 1.843

Review 7.  A molecular description of nerve terminal function.

Authors:  L F Reichardt; R B Kelly
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

8.  Coordinate regulation of gonadotropin-releasing hormone neuronal firing patterns by cytosolic calcium and store depletion.

Authors:  F Van Goor; L Z Krsmanovic; K J Catt; S S Stojilkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

9.  The presence in pig brain of an endogenous equivalent of apamin, the bee venom peptide that specifically blocks Ca2+-dependent K+ channels.

Authors:  M Fosset; H Schmid-Antomarchi; M Hugues; G Romey; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

10.  The effects of sevoflurane on lidocaine-induced convulsions.

Authors:  F Karasawa
Journal:  J Anesth       Date:  1991-01       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.